Cancer Care Coordination for Chemotherapy Patients

Not Applicable

Completed

• Conditions: Cancer

• Registration Number: NCT02238951
• Lead Sponsor: University of California, Davis

Brief Summary

The purpose of this study is to compare nurse-led care coordination for persons receiving cancer chemotherapy treatment incorporating mobile health technology to nurse-led care coordination without any mobile health enhancements.

Detailed Description

This study will randomize sixty (60) participants receiving cancer chemotherapy treatment to receive nurse-led care coordination using a HIPAA-compliant mobile health platform compared to no technology-enhanced care coordination.

All participants receive nurse-led care coordination throughout chemotherapy treatment.

RESEARCH AIMS:

* Demonstration of a HIPAA-compliant social networking platform;

* Facilitate communication and collaboration among patients with cancer and their care team;

* Assess patient health outcomes (chemotherapy-related physical and psychological side effects; pain, quality of life and patient satisfaction)

* Assessment of healthcare utilization including emergency department visits, unplanned clinic visits and hospitalization;

* For patients assigned to the mobile health care coordination, understanding their experience of use of the technology

Study Timeline

• Study Start: 2013-12
• Study First Submitted: 2014-09-10
• Study First Submitted QC: 2014-09-10
• Study First Posted: 2014-09-12
• Primary Completion: 2017-10
• Study Completion: 2017-10
• Status Verified: 2018-11
• Last Update Submitted: 2018-11-15
• Last Update Posted: 2018-11-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• 18 years or older
• Newly diagnosed cancer - any site or stage
• Initiating chemotherapy
• Ability to read and write English
• Manual dexterity sufficient to use a tablet technology
• Cognitive capacity to participate
• Preferential recruitment of publicly insured and/or living in rural communities

Exclusion Criteria

• Oral chemotherapy

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Change in Patient Health Outcome	Baseline, 3 months, 6 months	Pain

Secondary Outcome Measures

Name	Time	Method
Demonstration of a HIPAA-compliant platform to coordinate care overtime	Baseline, 6 months	* Technology Usability and Acceptance; * Patient engagement with technology; * Use of electronic medical record features to communicate with providers

Trial Locations

Locations (1)

UC Davis Comprehensive Cancer Care Center; 🇺🇸 Sacramento, California, United States